Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
Author:
Funder
Jan Wallanders och Tom Hedelius Stiftelse samt Tore Browaldhs Stiftelse
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference52 articles.
1. The cost of cancer in Europe 2018;Hofmarcher;Eur J Cancer,2020
2. Economic burden of cancer across the European Union: a population-based cost analysis;Luengo-Fernandez;Lancet Oncol,2013
3. Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014;Savage;Br J Cancer,2015
4. Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009;Savage;J Oncol Pharm Pract,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of competition on reimbursement decisions for cancer drugs in China: an observational study;The Lancet Regional Health - Western Pacific;2024-09
2. Quantifying societal burden of radiation-induced small bowel toxicity in patients with rectal cancer;Frontiers in Oncology;2024-07-08
3. Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies;BMC Cancer;2024-03-06
4. Integrating Artificial Intelligence for Academic Advanced Therapy Medicinal Products: Challenges and Opportunities;Applied Sciences;2024-02-05
5. The reimbursement decision speed for oncology new drugs in China and its determinant factors;Frontiers in Public Health;2023-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3